首页> 外文期刊>World Journal of Gastroenterology >Can HB vaccine yield a booster effect on individuals with positive serum anti-HBs and anti-HBc markers?
【24h】

Can HB vaccine yield a booster effect on individuals with positive serum anti-HBs and anti-HBc markers?

机译:HB疫苗能否对血清抗HBs和抗HBc标记阳性的人产生增强作用?

获取原文
获取原文并翻译 | 示例
       

摘要

AIM: To evaluate if HB vaccination can yield a booster effect on the anti-HBs level of those naturally acquired HBV positive markers. METHODS: Sera were collected from 1399 newly enrolled university students aged between 18-20 years at the entrance medical examination in 2001. Forty-four students (28 males and 16 females) with positive serum anti-HBs and anti-HBc markers served as an observation group and another 44 students (24 males and 20 females) without any HBV markers as the control. HB vaccination was given to all the students without positive serum HBsAg according to 0, 1, 6 month regimen and the peripheral venous blood was sampled from those of both observation and control groups for anti-HBs detection one month after the second and third doses. Anti-HBs levels were measured by ELISA. RESULTS: The seroconversion rate of anti-HBs in the control group was 100% after the second dose, but the geometric mean titers (GMTs) were low. The tendency of serum anti-HBs changes after the 3rd dose was completely different between the two groups. Although more than half of those with positive anti-HBs and anti-HBc showed a mild increase of anti-HBs levels after the 2nd boosting dose (mean anti-HBs level was 320:198 mIU), but the increase of serum anti-HBs titer was much smaller than that in the control group. The averages of their initial serum anti-HBs levels and the levels after the 2nd and 3rd doses were 198, 320 and 275 mIU respectively. All the subjects from the control group had an obvious increase in their serum anti-HBs levels which was nearly 4 times the baseline level (302:78 mIU). CONCLUSION: HB vaccination can not enhance anti-HBs levels in those with positive serum anti-HBs and anti-HBc markers.
机译:目的:评估乙肝疫苗接种是否可以增强那些天然获得的乙肝病毒阳性标志物的抗乙肝水平。方法:从2001年入学体检的1399名年龄在18至20岁之间的新入学大学生中收集血清。44名血清抗HBs和抗HBc标记阳性的学生(28名男性和16名女性)作为血清样本。观察组和另外44名没有任何HBV标志物的学生(24名男性和20名女性)作为对照。根据第0、1、6个月的方案,对所有血清HBsAg无阳性的学生进行乙肝疫苗接种,并在第二和第三次给药后一个月从观察组和对照组中抽取外周静脉血进行抗HBs检测。通过ELISA测量抗HBs水平。结果:第二剂后,对照组抗HBs的血清转化率为100%,但几何平均滴度(GMT)较低。两组在第3次给药后血清抗HBs变化趋势完全不同。尽管超过一半的抗HBs和抗HBc阳性者在第二次加强剂量后抗HBs轻度升高(平均抗HBs水平为320:198 mIU),但血清抗HBs升高滴度比对照组小得多。其初始血清抗-HBs水平的平均值以及第二和第三次给药后的平均值分别为198、320和275 mIU。对照组的所有受试者血清抗HBs水平均明显升高,几乎是基线水平的四倍(302:78 mIU)。结论:在血清抗HBs和抗HBc标记阳性的人群中,乙肝疫苗不能提高抗HBs水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号